세계의 바이오의약품용 플라스틱 시장 : 폴리머별, 용도별 - 기회 분석 및 산업 예측(2023-2032년)

According to a new report published by Allied Market Research, titled, "Biopharma Plastics Market," The biopharma plastics market was valued at $5.0 billion in 2022, and is estimated to reach $14.9 billion by 2032, growing at a CAGR of 11.6% from 2023 to 2032.

Biologics are therapeutic products derived from living organisms and play a crucial role in treating various complex diseases like cancer, autoimmune disorders, and infectious diseases. As the demand for biologics continues to surge, so does the need for specialized packaging, storage, and delivery systems made from biopharma plastics. Personalized medicines, tailored to individual patients based on their genetic makeup and specific health conditions, have gained momentum as a promising approach to enhance treatment efficacy and reduce adverse effects. Plastics are essential in manufacturing customized drug delivery devices, such as injectable pens, inhalers, and implantable devices, ensuring accurate dosing and patient compliance.

The unique properties of biopharma plastics, including biocompatibility, chemical resistance, and the ability to maintain the stability of sensitive biologic drugs, make them ideal materials for use in the biopharmaceutical industry. Additionally, advancements in plastic manufacturing technologies have led to the development of innovative and specialized plastic materials, further driving the demand for biopharma plastics in the production of advanced drug delivery systems. As the healthcare sector continues to focus on precision medicine and the development of novel biologics, the biopharma plastics market is expected to witness significant growth.

The high cost of biopharma plastics is expected to hinder the growth and expansion of the biopharma plastics market. While these specialized plastic materials offer unique properties and advantages that cater to the stringent requirements of the biopharmaceutical industry, their production involves sophisticated technologies and raw materials, leading to elevated manufacturing costs. The significant expenses incurred during the production process are ultimately passed on to the end-users, including pharmaceutical companies, research laboratories, and healthcare institutions, making biopharma plastics an expensive choice for medical devices and drug packaging. The cost factor poses challenges for small and medium-sized enterprises (SMEs) and emerging pharmaceutical companies, which may find it financially burdensome to adopt biopharma plastics in their operations. As a result, these organizations might opt for more economical alternatives, potentially limiting the market demand for biopharma plastics. Additionally, stringent budget constraints in the healthcare sector, especially in developing regions, may deter the widespread adoption of high-cost biopharma plastics, thereby impeding market growth.

Advancements in biopharma plastic technologies are set to present highly lucrative opportunities to the biopharma plastics market. As the biopharmaceutical industry continues to advance and evolve, there is an increasing demand for innovative materials that can meet the specific needs and challenges of drug development, manufacturing, and delivery. Biopharma plastic technologies have been at the forefront of addressing these requirements, offering a wide range of cutting-edge solutions. One key area of advancement is the development of novel biomaterials with enhanced properties such as improved biocompatibility, reduced leachable and extractable, and better resistance to chemical interactions. These advancements ensure that the plastic materials used in pharmaceutical applications do not compromise the safety and efficacy of drugs, making them ideal for critical uses such as drug packaging, containers, and medical devices.

Moreover, the progress in nanotechnology and nanomaterials has enabled the creation of specialized plastic particles and coatings that can improve drug delivery systems, enabling targeted and controlled release of medications. This opens up new avenues for personalized medicine and enhances patient outcomes. Additionally, the integration of smart technologies into biopharma plastics is gaining momentum. These technologies include sensors, indicators, and tracking mechanisms that can monitor the condition and integrity of drugs during storage and transportation, ensuring product quality and patient safety.

The biopharma plastics market is segmented on the basis of polymer, application, and region. By polymer, the market is divided into polyethylene, polypropylene, acrylonitrile butadiene styrene, polyethylene terephthalate, polyvinyl chloride, polytetrafluoroethylene, and others. On the basis of the application, it is categorized into protective wear, containers, bioreactor bags, syringes, depth filters, disposable medical connectors, and others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

The major players operating in the global biopharma plastics market are BASF SE, SABIC, DOW Inc, Covestro AG, Formosa Plastics Corporation, Solvay, TORAY INDUSTRIES, INC., LyondellBasell Industries Holdings B.V., Mitsui & Co. Plastics Ltd, and INEOS Group.

Other Players include Thermo Fisher Scientific, GE Healthcare, Lonza Group, Corning Incorporated, Saint-Gobain Life Sciences, Eppendorf AG, Merck KGaA, Pall Corporation, Entegris, Inc., Meissner Filtration Products, Inc., Repligen Corporation, West Pharmaceutical Services, Inc., Agilent Technologies and IDEX Health & Science LLC.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the biopharma plastics market analysis from 2022 to 2032 to identify the prevailing biopharma plastics market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the biopharma plastics market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global biopharma plastics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

• Analysis of raw material in a product (by %)
• Manufacturing Capacity
• End user preferences and pain points
• Investment Opportunities
• Product Benchmarking / Product specification and applications
• Product Life Cycles
• Senario Analysis & Growth Trend Comparision
• Supply Chain Analysis & Vendor Margins
• Upcoming/New Entrant by Regions
• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Average Selling Price Analysis / Price Point Analysis
• Brands Share Analysis
• Expanded list for Company Profiles
• Historic market data
• Import Export Analysis/Data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)
• List of customers/consumers/raw material suppliers- value chain analysis
• Market share analysis of players at global/region/country level
• Product Consumption Analysis
• Volume Market Size and Forecast

Key Market Segments

By Application

• Protective Wear
• Containers
• Bioreactor Bags
• Syringes
• Depth Filters
• Disposable Medical Connectors
• Others

By Polymer

• Polyethylene
• Polypropylene
• Acrylonitrile Butadiene Styrene
• Polyethylene Terephthalate
• Polyvinyl Chloride
• Polytetrafluoroethylene
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• BASF SE
• SABIC
• Solvay
• LyondellBasell Industries Holdings B.V.
• Dow Inc.
• Covestro AG.
• INEOS Group
• Formosa Plastics Corporation
• Mitsui & Co.Plastics Ltd
• TORAY INDUSTRIES, INC.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research Methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Modearte bargaining power of suppliers
  • 3.3.2. Moderate threat of new entrants
  • 3.3.3. High threat of substitutes
  • 3.3.4. High intensity of rivalry
  • 3.3.5. High bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Growing demand for sustainable packaging
    • 3.4.1.2. Rising adoption of biologics and personalized medicines

• 3.4.2. Restraints
  • 3.4.2.1. High cost of biopharma plastics

• 3.4.3. Opportunities
  • 3.4.3.1. Advancements in biopharma plastic technologies

• 3.5. COVID-19 Impact Analysis on the market
• 3.6. Market Share Analysis
• 3.7. Value Chain Analysis
• 3.8. Regulatory Guidelines
• 3.9. Patent Landscape
• 3.10. Pricing Analysis

CHAPTER 4: BIOPHARMA PLASTICS MARKET, BY POLYMER

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Polyethylene
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Polypropylene
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Acrylonitrile Butadiene Styrene
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country
• 4.5. Polyethylene Terephthalate
  • 4.5.1. Key market trends, growth factors and opportunities
  • 4.5.2. Market size and forecast, by region
  • 4.5.3. Market share analysis by country
• 4.6. Polyvinyl Chloride
  • 4.6.1. Key market trends, growth factors and opportunities
  • 4.6.2. Market size and forecast, by region
  • 4.6.3. Market share analysis by country
• 4.7. Polytetrafluoroethylene
  • 4.7.1. Key market trends, growth factors and opportunities
  • 4.7.2. Market size and forecast, by region
  • 4.7.3. Market share analysis by country
• 4.8. Others
  • 4.8.1. Key market trends, growth factors and opportunities
  • 4.8.2. Market size and forecast, by region
  • 4.8.3. Market share analysis by country

CHAPTER 5: BIOPHARMA PLASTICS MARKET, BY APPLICATION

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Protective Wear
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Containers
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Bioreactor Bags
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Syringes
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country
• 5.6. Depth Filters
  • 5.6.1. Key market trends, growth factors and opportunities
  • 5.6.2. Market size and forecast, by region
  • 5.6.3. Market share analysis by country
• 5.7. Disposable Medical Connectors
  • 5.7.1. Key market trends, growth factors and opportunities
  • 5.7.2. Market size and forecast, by region
  • 5.7.3. Market share analysis by country
• 5.8. Others
  • 5.8.1. Key market trends, growth factors and opportunities
  • 5.8.2. Market size and forecast, by region
  • 5.8.3. Market share analysis by country

CHAPTER 6: BIOPHARMA PLASTICS MARKET, BY REGION

• 6.1. Overview
  • 6.1.1. Market size and forecast By Region
• 6.2. North America
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by Polymer
  • 6.2.3. Market size and forecast, by Application
  • 6.2.4. Market size and forecast, by country
    • 6.2.4.1. U.S.
    • 6.2.4.1.1. Market size and forecast, by Polymer
    • 6.2.4.1.2. Market size and forecast, by Application
    • 6.2.4.2. Canada
    • 6.2.4.2.1. Market size and forecast, by Polymer
    • 6.2.4.2.2. Market size and forecast, by Application
    • 6.2.4.3. Mexico
    • 6.2.4.3.1. Market size and forecast, by Polymer
    • 6.2.4.3.2. Market size and forecast, by Application
• 6.3. Europe
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by Polymer
  • 6.3.3. Market size and forecast, by Application
  • 6.3.4. Market size and forecast, by country
    • 6.3.4.1. Germany
    • 6.3.4.1.1. Market size and forecast, by Polymer
    • 6.3.4.1.2. Market size and forecast, by Application
    • 6.3.4.2. UK
    • 6.3.4.2.1. Market size and forecast, by Polymer
    • 6.3.4.2.2. Market size and forecast, by Application
    • 6.3.4.3. France
    • 6.3.4.3.1. Market size and forecast, by Polymer
    • 6.3.4.3.2. Market size and forecast, by Application
    • 6.3.4.4. Spain
    • 6.3.4.4.1. Market size and forecast, by Polymer
    • 6.3.4.4.2. Market size and forecast, by Application
    • 6.3.4.5. Italy
    • 6.3.4.5.1. Market size and forecast, by Polymer
    • 6.3.4.5.2. Market size and forecast, by Application
    • 6.3.4.6. Rest of Europe
    • 6.3.4.6.1. Market size and forecast, by Polymer
    • 6.3.4.6.2. Market size and forecast, by Application
• 6.4. Asia-Pacific
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by Polymer
  • 6.4.3. Market size and forecast, by Application
  • 6.4.4. Market size and forecast, by country
    • 6.4.4.1. China
    • 6.4.4.1.1. Market size and forecast, by Polymer
    • 6.4.4.1.2. Market size and forecast, by Application
    • 6.4.4.2. India
    • 6.4.4.2.1. Market size and forecast, by Polymer
    • 6.4.4.2.2. Market size and forecast, by Application
    • 6.4.4.3. Japan
    • 6.4.4.3.1. Market size and forecast, by Polymer
    • 6.4.4.3.2. Market size and forecast, by Application
    • 6.4.4.4. South Korea
    • 6.4.4.4.1. Market size and forecast, by Polymer
    • 6.4.4.4.2. Market size and forecast, by Application
    • 6.4.4.5. Australia
    • 6.4.4.5.1. Market size and forecast, by Polymer
    • 6.4.4.5.2. Market size and forecast, by Application
    • 6.4.4.6. Rest of Asia-Pacific
    • 6.4.4.6.1. Market size and forecast, by Polymer
    • 6.4.4.6.2. Market size and forecast, by Application
• 6.5. LAMEA
  • 6.5.1. Key market trends, growth factors and opportunities
  • 6.5.2. Market size and forecast, by Polymer
  • 6.5.3. Market size and forecast, by Application
  • 6.5.4. Market size and forecast, by country
    • 6.5.4.1. Brazil
    • 6.5.4.1.1. Market size and forecast, by Polymer
    • 6.5.4.1.2. Market size and forecast, by Application
    • 6.5.4.2. Saudi Arabia
    • 6.5.4.2.1. Market size and forecast, by Polymer
    • 6.5.4.2.2. Market size and forecast, by Application
    • 6.5.4.3. South Africa
    • 6.5.4.3.1. Market size and forecast, by Polymer
    • 6.5.4.3.2. Market size and forecast, by Application
    • 6.5.4.4. Rest of LAMEA
    • 6.5.4.4.1. Market size and forecast, by Polymer
    • 6.5.4.4.2. Market size and forecast, by Application

CHAPTER 7: COMPETITIVE LANDSCAPE

• 7.1. Introduction
• 7.2. Top winning strategies
• 7.3. Product Mapping of Top 10 Player
• 7.4. Competitive Dashboard
• 7.5. Competitive Heatmap
• 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

• 8.1. BASF SE
  • 8.1.1. Company overview
  • 8.1.2. Key Executives
  • 8.1.3. Company snapshot
  • 8.1.4. Operating business segments
  • 8.1.5. Product portfolio
  • 8.1.6. Business performance
• 8.2. SABIC
  • 8.2.1. Company overview
  • 8.2.2. Key Executives
  • 8.2.3. Company snapshot
  • 8.2.4. Operating business segments
  • 8.2.5. Product portfolio
  • 8.2.6. Business performance
• 8.3. Dow Inc.
  • 8.3.1. Company overview
  • 8.3.2. Key Executives
  • 8.3.3. Company snapshot
  • 8.3.4. Operating business segments
  • 8.3.5. Product portfolio
  • 8.3.6. Business performance
• 8.4. Covestro AG.
  • 8.4.1. Company overview
  • 8.4.2. Key Executives
  • 8.4.3. Company snapshot
  • 8.4.4. Operating business segments
  • 8.4.5. Product portfolio
  • 8.4.6. Business performance
• 8.5. Formosa Plastics Corporation
  • 8.5.1. Company overview
  • 8.5.2. Key Executives
  • 8.5.3. Company snapshot
  • 8.5.4. Operating business segments
  • 8.5.5. Product portfolio
  • 8.5.6. Business performance
• 8.6. Solvay
  • 8.6.1. Company overview
  • 8.6.2. Key Executives
  • 8.6.3. Company snapshot
  • 8.6.4. Operating business segments
  • 8.6.5. Product portfolio
  • 8.6.6. Business performance
• 8.7. TORAY INDUSTRIES, INC.
  • 8.7.1. Company overview
  • 8.7.2. Key Executives
  • 8.7.3. Company snapshot
  • 8.7.4. Operating business segments
  • 8.7.5. Product portfolio
  • 8.7.6. Business performance
• 8.8. LyondellBasell Industries Holdings B.V.
  • 8.8.1. Company overview
  • 8.8.2. Key Executives
  • 8.8.3. Company snapshot
  • 8.8.4. Operating business segments
  • 8.8.5. Product portfolio
  • 8.8.6. Business performance
• 8.9. Mitsui & Co.Plastics Ltd
  • 8.9.1. Company overview
  • 8.9.2. Key Executives
  • 8.9.3. Company snapshot
  • 8.9.4. Operating business segments
  • 8.9.5. Product portfolio
  • 8.9.6. Business performance
• 8.10. INEOS Group
  • 8.10.1. Company overview
  • 8.10.2. Key Executives
  • 8.10.3. Company snapshot
  • 8.10.4. Operating business segments
  • 8.10.5. Product portfolio
  • 8.10.6. Business performance